Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promising effect of intravenous immunoglobulin therapy for epidermolysis bullosa pruriginosa.

International journal of dermatology - 1 Jul 2020

Ertop Pelin, Vural Secil, Gökpınar Ili Ezgi, Durmaz Ceren D, Heper Aylin O, McGrath John A, Ilgın Ruhi H, Boyvat Ayse

Abstract excerpt

BACKGROUND: Epidermolysis bullosa pruriginosa (EBP) is rare a clinical variant of dystrophic epidermolysis bullosa characterized by trauma-induced bullae formation, milia and nail dystrophy accompanied by severe pruritus. Treatment pruritus of EBP focuses on immunosuppressive treatment with limited efficacy. Treatment strategies are not well-established. AIM: To provide the genetic characterization of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Collagen Type VII
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epidermolysis Bullosa Dystrophica

Share to Heterozygote

Share to Immunoglobulins, Intravenous

Share to Pedigree

Share to Retreatment

Share to Young Adult

Source

Identifiers

PMID: 32506551
DOI: 10.1111/ijd.14951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promising effect of intravenous immunoglobulin therapy for epidermolysis bullosa pruriginosa.PMID 32506551Read ↗

Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity.Semantic proximity Read ↗

Epidermolysis bullosa pruriginosa: a systematic review exploring genotype-phenotype correlation.Semantic proximity Read ↗

Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.Semantic proximity Read ↗

Innovative therapeutic strategies for recessive dystrophic epidermolysis bullosa.Semantic proximity Read ↗

Treatment of Epidermolysis Bullosa and Future Directions: A ReviewSemantic proximity Read ↗

Genetic Profile of Epidermolysis Bullosa Cases in King Abdulaziz Medical City, Riyadh, Saudi ArabiaSemantic proximity Read ↗

Epidermolysis Bullosa. Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa RegistrySemantic proximity Read ↗

Novel pathogenic variants in an Indian cohort with epidermolysis bullosa: Expanding the genotypic spectrum.Semantic proximity Read ↗

Recent advances in understanding and managing epidermolysis bullosaSemantic proximity Read ↗

Intravenous allogeneic umbilical cord blood-derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients.Semantic proximity Read ↗

Epidermolysis bullosa pruriginosa: a case with prominent histopathologic inflammation.Semantic proximity Read ↗

Recently Identified Forms of Epidermolysis BullosaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.